CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.
about
Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligasesIdentifying mutation specific cancer pathways using a structurally resolved protein interaction network.Dasatinib targets B-lineage cells but does not provide an effective therapy for myeloproliferative disease in c-Cbl RING finger mutant mice.Novel somatic and germline mutations in intracranial germ cell tumours.UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO.Somatic SETBP1 mutations in myeloid malignanciesBRCC3 mutations in myeloid neoplasms.Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.Preclinical and phase I results of decitabine in combination with midostaurin (PKC412) for newly diagnosed elderly or relapsed/refractory adult patients with acute myeloid leukemia.Pilot assessment of vascular endothelial growth factor receptors and trafficking pathways in recurrent and metastatic canine subcutaneous mast cell tumours.
P2860
Q26852269-9270ED30-A477-4753-86CE-E572931D0CAEQ30370822-F3B5B47C-12DE-4673-B28A-EF1C7F03EE2DQ35144330-267182EF-D3DF-4921-AB4A-E10CB346E261Q35940152-241950C4-F816-47C4-8D31-9B0DC02BD2B9Q36642902-4D898B36-37EA-4DAC-A2B7-7E70A7D81FB8Q37060418-70A9CC47-1BB8-4051-94E0-63DC7439C9D2Q37216363-504EA329-7F4F-4BC0-9E0B-B232D0414C46Q38721532-63504CFC-B3E0-4FFA-9EBB-FC7E6DF70BE1Q39135512-23815501-6C8F-43AC-8C1D-BF1F0142BE65Q42682714-8BDE809E-8AA0-4FC7-BADD-A4D09A4F3195
P2860
CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
CBL mutation-related patterns ...... to tyrosine kinase inhibitors.
@en
CBL mutation-related patterns ...... to tyrosine kinase inhibitors.
@nl
type
label
CBL mutation-related patterns ...... to tyrosine kinase inhibitors.
@en
CBL mutation-related patterns ...... to tyrosine kinase inhibitors.
@nl
prefLabel
CBL mutation-related patterns ...... to tyrosine kinase inhibitors.
@en
CBL mutation-related patterns ...... to tyrosine kinase inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
CBL mutation-related patterns ...... to tyrosine kinase inhibitors.
@en
P2093
H Makishima
H Muramatsu
J P Maciejewski
M J Clemente
Y Saunthararajah
Y Sugimoto
P2860
P2888
P304
P356
10.1038/LEU.2012.7
P577
2012-01-13T00:00:00Z